Merit Medical Systems, Inc. Expected to Post Q4 2017 Earnings of $0.30 Per Share (MMSI)

Merit Medical Systems, Inc. (NASDAQ:MMSI) – Equities research analysts at Barrington Research increased their Q4 2017 earnings estimates for Merit Medical Systems in a report released on Thursday. Barrington Research analyst M. Petusky now expects that the medical instruments supplier will post earnings per share of $0.30 for the quarter, up from their previous forecast of $0.29. Barrington Research also issued estimates for Merit Medical Systems’ Q1 2018 earnings at $0.27 EPS and Q4 2018 earnings at $0.39 EPS.

Merit Medical Systems (NASDAQ:MMSI) last announced its quarterly earnings results on Wednesday, July 26th. The medical instruments supplier reported $0.36 EPS for the quarter, beating the Zacks’ consensus estimate of $0.29 by $0.07. Merit Medical Systems had a net margin of 4.87% and a return on equity of 9.78%. The firm had revenue of $186.50 million during the quarter, compared to the consensus estimate of $181.46 million. During the same quarter last year, the firm earned $0.26 EPS. The firm’s revenue for the quarter was up 23.4% compared to the same quarter last year. ILLEGAL ACTIVITY WARNING: “Merit Medical Systems, Inc. Expected to Post Q4 2017 Earnings of $0.30 Per Share (MMSI)” was posted by Community Financial News and is the sole property of of Community Financial News. If you are accessing this report on another website, it was illegally stolen and reposted in violation of US & international copyright and trademark laws. The legal version of this report can be accessed at https://www.com-unik.info/2017/08/19/merit-medical-systems-inc-expected-to-post-q4-2017-earnings-of-0-30-per-share-mmsi-updated-updated.html.

MMSI has been the subject of several other research reports. Bank of America Corp began coverage on shares of Merit Medical Systems in a research note on Thursday, July 20th. They set a “buy” rating and a $44.00 price objective for the company. Sidoti reaffirmed a “buy” rating and set a $46.00 price objective (up previously from $41.00) on shares of Merit Medical Systems in a research note on Wednesday, June 28th. Wells Fargo & Company began coverage on shares of Merit Medical Systems in a research note on Wednesday, April 5th. They set an “outperform” rating and a $31.70 price objective for the company. BidaskClub raised shares of Merit Medical Systems from a “buy” rating to a “strong-buy” rating in a research note on Tuesday, June 27th. Finally, Canaccord Genuity reaffirmed a “buy” rating and set a $37.00 price objective on shares of Merit Medical Systems in a research note on Friday, April 28th. One analyst has rated the stock with a hold rating, eight have assigned a buy rating and one has given a strong buy rating to the stock. Merit Medical Systems has a consensus rating of “Buy” and a consensus target price of $39.74.

Shares of Merit Medical Systems (MMSI) traded up 0.61% on Monday, hitting $41.25. 113,714 shares of the company were exchanged. The stock has a market capitalization of $2.06 billion, a PE ratio of 58.76 and a beta of 1.24. The firm’s 50-day moving average is $37.63 and its 200-day moving average is $32.14. Merit Medical Systems has a 52-week low of $20.70 and a 52-week high of $42.25.

In other Merit Medical Systems news, Director Michael E. Stillabower sold 17,110 shares of the business’s stock in a transaction dated Friday, May 19th. The shares were sold at an average price of $33.71, for a total value of $576,778.10. Following the transaction, the director now directly owns 52,778 shares in the company, valued at approximately $1,779,146.38. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director F. Ann Millner sold 6,744 shares of the business’s stock in a transaction dated Wednesday, June 28th. The shares were sold at an average price of $38.15, for a total transaction of $257,283.60. Following the completion of the transaction, the director now owns 4,247 shares in the company, valued at $162,023.05. The disclosure for this sale can be found here. Insiders sold a total of 82,944 shares of company stock worth $2,944,127 over the last quarter. 5.60% of the stock is currently owned by company insiders.

A number of institutional investors have recently bought and sold shares of MMSI. Ameritas Investment Partners Inc. purchased a new position in Merit Medical Systems during the first quarter valued at $102,000. LS Investment Advisors LLC raised its position in Merit Medical Systems by 8.1% in the second quarter. LS Investment Advisors LLC now owns 3,694 shares of the medical instruments supplier’s stock valued at $141,000 after buying an additional 277 shares during the last quarter. SG Americas Securities LLC purchased a new position in Merit Medical Systems during the first quarter valued at $134,000. State of Alaska Department of Revenue raised its position in Merit Medical Systems by 13.1% in the first quarter. State of Alaska Department of Revenue now owns 5,430 shares of the medical instruments supplier’s stock valued at $156,000 after buying an additional 630 shares during the last quarter. Finally, Cornerstone Capital Management Holdings LLC. raised its position in Merit Medical Systems by 2,513.6% in the first quarter. Cornerstone Capital Management Holdings LLC. now owns 6,900 shares of the medical instruments supplier’s stock valued at $199,000 after buying an additional 6,636 shares during the last quarter. Institutional investors own 92.13% of the company’s stock.

Merit Medical Systems Company Profile

Merit Medical Systems, Inc is a manufacturer and marketer of disposable medical devices used in a range of interventional, diagnostic and therapeutic medical procedures. The Company operates in two segments: cardiovascular and endoscopy. The cardiovascular segment consists of cardiology and radiology devices, which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases, and includes embolotherapeutic, cardiac rhythm management (CRM), electrophysiology (EP), and interventional oncology and spine devices.

Earnings History and Estimates for Merit Medical Systems (NASDAQ:MMSI)

What are top analysts saying about Merit Medical Systems Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Merit Medical Systems Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit